You Should Watch These: Hologic (NASDAQ:HOLX), CGG SA (ADR) (NYSE:CGG), Precision Drilling Corporation (NYSE:PDS), Sky Solar Holdings, (NASDAQ:SKYS), Clovis Oncology (NASDAQ:CLVS)


Hologic Inc. (NASDAQ:HOLX) shares increased 1.34% in last trading session and ended the day at $37.87. HOLX Gross Margin is 51.20% and its has a return on assets of 1.40%. Hologic Inc. (NASDAQ:HOLX) quarterly performance is 14.83%. Hologic, Inc. (NASDAQ:HOLX) announced that it has launched, subject to market and other conditions, a private offering of $1.0 billion aggregate principal amount of its senior notes due 2022. Hologic intends to use the proceeds of the offering, plus available cash, to redeem its outstanding 6.25% senior notes due 2020 in the aggregate principal amount of $1.0 billion.

CGG SA (ADR) (NYSE:CGG) ended the last trading day at $6.46. Company weekly volatility is calculated as 3.21% and price to cash ratio as 4.77. CGG SA (ADR) (NYSE:CGG) showed a weekly performance of -5.00%. On 3 June, CGG SA (ADR) (NYSE:CGG) announced the launch of FALCON Plus, the newest release in the highly successful suite of FALCON airborne gravity gradiometer (AGG) systems, halving the survey data noise of the world’s best AGG and providing more effective exploration capabilities.

On 18 June, Precision Drilling Corporation (NYSE:PDS) shares moved down -2.54% and was closed at $6.91. PDS EPS growth in last 5 year was -29.00%. Precision Drilling Corporation (NYSE:PDS) year to date (YTD) performance is 16.04%.

Sky Solar Holdings, Ltd. (NASDAQ:SKYS) shares advanced 9.16% in last trading session and ended the day at $7.51. SKYS Gross Margin is 44.70% and its has a return on assets of -27.40%. Sky Solar Holdings, Ltd. (NASDAQ:SKYS) quarterly performance is -32.34%. Zacks upgraded shares of Sky Solar Holdings (NASDAQ:SKYS) from a hold rating to a buy rating in a research report released on Monday morning. Zacks currently has $10.00 price objective on the stock.

Clovis Oncology, Inc. (NASDAQ:CLVS) caters to the Healthcare space. Its weekly performance is 4.62%. On the last day of trading company shares ended up $91.18. Clovis Oncology, Inc. (NASDAQ:CLVS) distance from 50-day simple moving average (SMA50) is 5.68%. The Annual Meeting of Shareholders of Clovis Oncology, Inc. (NASDAQ:CLVS) was held on June 11, 2015. At the Annual Meeting, the shareholders of the Company voted on the Proposal two was a management proposal to hold an advisory vote on the compensation of the Company’s named executive officers, as described in the proxy materials. This proposal was approved.


Leave a Reply

Your email address will not be published. Required fields are marked *